Andrew Witty
Top Ten most popular articles on Pharmafile.com this week
March 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, BMS, Biocon, Martin Shkreli, Novartis, Right to try, US, pharma, top ten
Another week goes by, and we may have finally reached Spring here in the UK. Friday means its time for …
Andrew Witty takes on a new CEO position
March 15, 2018Medical Communications Andrew Witty, GSK, Optum, UnitedHealth, biotech, drugs, pharma, pharmaceutical
Andrew Witty, who made his name working his way up the ranks at GSK to become its CEO, has revealed …
Witty to lead way in fast-tracking medicine through UK system
November 3, 2017Medical Communications AAR, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical
The UK government has announced its response to the Accelerated Access Review that was published last year, with former GSK …
Witty, Ex-CEO of GSK, keeps busy with two new roles in two days
September 21, 2017Medical Communications : Pharma, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical
It was always unlikely that Andrew Witty, former CEO of GSK, would take his ‘retirement’ from the company literally, but …
Not long after leaving GSK, Andrew Witty dips toes back into water
July 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, G1 Therapeutics, GSK, biotech, drugs, pharma, pharmaceutical
Only a short while after leaving his position as CEO of GSK, it seems Andrew Witty cannot resist getting back …
UK pharma would benefit by remaining in EU, says ABPI
May 9, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Andrew Witty, EU, brexit, letter, observer, pascal soriot, remain, stay
With the EU vote approaching, the Association of the British Pharmaceutical Industry (ABPI) has brought together 93 signatories, including the …
GlaxoSmithKline opens new £56 million facility in Hertfordshire
April 19, 2016Manufacturing and Production Andrew Witty, GSK, GlaxoSmithKline, Sir Andrew Witty, ellipta, facility, george freeman, inhalers, manufacturing, new, respiratory, ware
GlaxoSmithKline has opened a new £56 million manufacturing facility in Hertfordshire, South-East England. The facility in Ware will create 150 …
Sir Andrew Witty announces decision to step down as CEO of GSK
March 17, 2016Medical Communications, Research and Development Andrew Witty, GSK, GlaxoSmithKline, Neil Woodford, Sir Andrew Witty, Witty, gsk break up, gsk split, retirement, steps down
Sir Andrew Witty has announced his decision to retire from his role as chief executive officer of pharmaceutical giant, GlaxoSmithKline …
Photo story: GSK’s 2012 legacy
May 30, 2012Research and Development Andrew Witty, GSK, Olympics 2012
Tuesday May 29, 2012: GlaxoSmithKline chief executive, Sir Andrew Witty makes a speech at a conference at the company’s headquarters …
Emerging markets no haven from HTA, says NICE
February 15, 2012Andrew Witty, GSK, NICE, NICE International
The head of NICE says pharma will face health technology assessment barriers in every country – including fast-growing developing markets. …
GSK’s Andrew Witty knighted
January 3, 2012Sales and Marketing Andrew Witty, GSK
GlaxoSmithKline chief executive Andrew Witty and former ABPI director general Richard Barker were among the recipients in the 2012 New …
Pharma engages HTA bodies in early-stage drug discussions
October 27, 2010Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, EMA, European Medicines Agency, GlaxoSmithKline, Johnson & Johnson, health technology assessment, hta
Three pharma companies are taking part in a new pilot to harmonise European standards in health technology assessment (HTA). AstraZeneca, …
GSK’s Andrew Witty appointed president of EFPIA
January 5, 2010Research and Development, Sales and Marketing Andrew Witty, EFPIA, GSK, appointment, research and development, sales and marketing
GlaxoSmithKline chief executive Andrew Witty has been appointed president of EFPIA.He previously served as vice-president of the European industry association for two years and takes …
